ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,596Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 21

$604K Total Retail Price of All Prescriptions

Rank: 4 out of 21

369 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 11,037 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
WARFARIN SODIUM 784 683 1 9
LEVOTHYROXINE SODIUM 533 531 2 1
HYDROCODONE-ACETAMINOPHEN 504 428 S3 3 3
OMEPRAZOLE 471 427 4 4
SIMVASTATIN 357 330 5 2
LISINOPRIL 351 289 6 7
AMLODIPINE BESYLATE 326 314 7 8
POTASSIUM CHLORIDE 305 271 8 6
CITALOPRAM HBR 297 265 9 12
GABAPENTIN 283 230 10 11
FUROSEMIDE 264 251 11 5
METFORMIN HCL 216 187 12 10
LOSARTAN POTASSIUM 215 195 13 17
CARVEDILOL 177 177 14 26
FLUTICASONE PROPIONATE 174 129 15 48
CYMBALTA 160 136 16 30
MELOXICAM 141 109 17 22
MIRTAZAPINE 137 137 18 53
CEFUROXIME 134 122 19 96
METOPROLOL TARTRATE 132 128 20 15
PANTOPRAZOLE SODIUM 118 107 21 31
HYDROCHLOROTHIAZIDE 112 105 22 14
SERTRALINE HCL 104 104 23 35
ATORVASTATIN CALCIUM 98 77 24 19
LANTUS 96 76 25 34
TRAMADOL HCL 95 48 26 16
ZOLPIDEM TARTRATE 95 76 26 21
TAMSULOSIN HCL 91 91 28 36
NAMENDA 88 88 29 28
POLYETHYLENE GLYCOL 3350 88 87 29 18
ATENOLOL 87 82 31 13
GLIMEPIRIDE 86 86 32 42
LOVASTATIN 83 73 33 45
ALENDRONATE SODIUM 83 73 33 27
ADVAIR DISKUS 81 66 35 58
SYNTHROID 78 70 36 70
LEVOFLOXACIN 77 64 37 58
FENOFIBRATE 76 68 38 92
LIDODERM 75 75 39 99
METOPROLOL SUCCINATE 74 73 40 20
FAMOTIDINE 74 61 40 62
TRAZODONE HCL 66 32 42 56
BACLOFEN 64 44 43 97
PAROXETINE HCL 64 48 43 41
ESCITALOPRAM OXALATE 61 60 45 92
PROAIR HFA 59 31 46 39
VESICARE 58 58 47 141
ALLOPURINOL 58 58 47 23
LANTUS SOLOSTAR 56 44 49 146
LYRICA 55 43 50 105
OXYCODONE HCL 55 0 S2 50 81
PREDNISONE 54 33 52 24
DIGOXIN 54 47 52 29
TRIMETHOPRIM 53 53 54 150
CARBIDOPA-LEVODOPA 53 53 54 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 41 54 51
IPRATROPIUM-ALBUTEROL 50 49 57 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.